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Post-operative analgesia currently relies on multimodal therapy including epidural analgesia, intravenous 
morphine and/or paracetamol (Perfalgan 9 ) infusion. Local wound infusion has been effectively util ized in 
adults with promising results but has not been prospectively tested in children undergoing different abdominal 
operations. The aim of this study was to compare continuous local anesthetic wound infusion to the current 
standard of care in post-operative pain control in children. 
Methods: We conducted a prospective randomized, pain assessor blinded trial comparing Bupivacaine wound 
infusion {Continuous Local Anaesthetic Wound Infusion - CLAWI) in addition to intravenous paracetamol 
(Perfalgan• ) and morphine for rescue analgesia. This was compared to: (a) epidural bupivacaine plus 
intravenous morphine and Perfalgan• [EPI] for children undergoing open abdominal surgery and (b) 
intravenous morphine and Perfalgan• infusion alone [standard post-operative analgesia - SAPA] in children 
undergoing Lanz incision laparotomy for complicated appendicitis. 
Patients aged between 3 months and 12 years undergoing laparotomy or open appendectomy were randomly 
selected for local anesthetic wound infusion (CLAWI) versus EPI or CLAWI versus (SAPA) respectively. Exclusion 
criteria were neurological impairment, post-operative ventilation and history of adverse reaction to 
bupivacaine. Consent from the guardian, assent from patients above the age of 7 years and ethics approval 
from the University of Cape Town Human Ethics Research Committee was obtained. The wound infusion 
catheter ('lnfiltralLong', PANJUNK411 ) was placed sub-fascially after suture of the peritoneum and 0.2 % 
bupivacaine 2mls/kg infused on anesthetic reversal followed by 0.2ml/kg/hour thereafter for 48 hours. Pain 
assessments were performed for each patient at regular intervals by a single assessor who had training in 
pediatric pain management and who was blinded to the group allocation. The duration of surgery, length of 
incision, perioperative antibiotics, wound class risk of surgical site infection, time to return to full feeds, drug 
reactions; hospital stay, surgical site infection and wound catheter and epidural catheter complications were 
recorded for each patient. Primary outcome measure was total morphine used in the appendectomy-SAPA vs 
appendectomy-CLAW! group and rescue morphine requirements in the laparotomy-EPI vs laparotomy-CLAWI 
group. The secondary outcomes were pain control as measured using the FLACC scale, time to full feeds, 
mobilization and requirement for urinary catheter. 
Results: Sixty patients (18 Laparotomy-CLAWI (LAP-CLAWI), 17 Laparotomy-EPI (LAP-EPI) and 12 
Appendectomy-CLAW! (APP-CLAWI), 13 Appendectomy-SAPA (APP-SAPA)) were analyzed. 
Within these two main study groups, the subgroup demographic, clinical variables and secondary outcome 
variables were analyzed for frequencies/percentage, means and standard deviation as appropriate. The 
Student's t-test was used for continuous variables and Chi-square for categorical variables to assess for 
differences between subgroups. Total morphine requirement for the APP-SAPA vs APP-CLAWI groups were 
calculated for each patient and expressed as a mean and standard deviation for each subgroup. Total rescue 
morphine requirements were used in the LAP-EPI vs LAP-CLAWI groups. The Student's t-test was used to 
compare morphine requirements between subgroups. Pain scores were recorded at multiple regular intervals 
for each study participant. Each participant had a total of eight pain scores done by the blinded pain assessor. 
A time series of pain scores for each subgroup was created and used to compare pain control trends between 
groups. A mean and standard deviation of the pain scores was also calculated and the means compared 
between subgroups using the t-test. The average FLACC (Face, Legs, Activity, Cry & Consolability) pain score in 
the CLAW! groups was 2.5 [=minimal pain] (1-4) and 3.0 (1-5) in the EPI group and 3.5 (2-5) in the SAPA group. 
Mean morphine requirements were significantly higher in the control groups: Appendectomy-standard 
analgesia group had a mean of 490ug compared to 96 ug in the infusion group, p-value 0.016. Laparotomy-
epidural group had a mean morphine requirement of 406ug compared to a mean of 230ug in the infusion 
group, p-value 0.052. The SAPA and EPJ group had a longer duration to removal of urinary catheter and 
mobilization (average 4 days vs. 2 days in the CLAWI group). Time to full feeds was comparable in all groups. 
There were no wound infections and no bupivacaine related complications in the CLAWI group. 
Conclusion: Continuous subfascial bupivacaine infusion is a reliable, safe and effective technique for post-
operative pain control in children undergoing open abdominal surgery. It is comparable to current standard of 
care and has the benefit of a considerably reduced requirement for opioid analgesia in children undergoing 
various abdominal operations. 
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INTRODUCTION 
Postoperative pain is a cause of morbidity and contributes indirectly to prolonged hospital stay and 
cost of care. For these reasons and to ensure quality patient care, the control of pain in the 
postoperative period is paramount for optimal outcomes in pediatric surgery. 
The current methods of postoperative pain management are prone to complications and vary in 
their effectiveness. Furthermore the application of standardized tools of assessment of pain in the 
pediatric population is not widely utilized. 
Local anesthetic as a continuous infusion in the subfascial space of the surgical wound for 
postoperative pain control has been used in adult patients with promising results. However, its 
application in pediatric patients (age more than 3 months to 12 years) has not been adopted in most 
centers. Controlled trials comparing standard postoperative analgesia to continuous subfascial 
bupivacaine infusion for children undergoing different abdominal operations are few. 
There is also limited information on the physiological benefits of subfascial local anaesthetic wound 
infusion in pediatrics in terms of return to bowel function, need for urethral catheterization, hospital 
stay as well as rates of surgical site infection and short term wound complications. 
We conducted a pain assessor blinded randomized control trial comparing subfascial bupivacaine 
wound infusion to the standard of care in post-operative analgesia to determine the morphine 
requirements among patients undergoing varied abdominal operations. The other endpoints were to 
determine the rates of surgical site infections, local wound infusion related complications, length of 
hospital stay, the time to resumption of full feeds, need for and duration of urethral catheterization 
and mortality. 
8 
CHAPTER 1: LITERATURE REVIEW 
1.1 PAIN 
The International Association for the Study of Pain (IASP) defines pain as "an unpleasant sensory and 
emotional experience associated with actual or potential tissue damage". It is a combination of 
unpleasant sensory, emotional and mental experiences which are associated with autonomic, 
psychological, and behavioral responses[l] . 
Pain has plagued mankind since we can remember and has been described by some as "a problem of 
epidemic proportions"[2]. In the Montreal declaration of 2011, pain control was adopted as a human 
right(3-4). 
1.2 POSTOPERATIVE PAIN 
Although there is a degree of overlap, pain can be classified as inflammatory/acute or 
neuropathic/chronic. This classification is founded on the understanding of the pathways involved in 
the onset and evolution of pain in surgical practice. It informs to a large extent, the design and 
application of targeted therapies and monitoring tools(S-6). One of the factors associated with the 
transition from acute to chronic pain is inadequate postoperative analgesia[S]. 
Postoperative pain falls in the acute category. Surgery causes tissue damage including injury to the 
peripheral nerves. This leads to local and regional inflammatory reaction accompanied by a local, 
regional and systemic neural response. The local effects of these reactions include wound site tissue 
hypo-perfusion. The systemic effects include reduced general movement and respiratory effort as a 
result of skeletal and diaphragmatic splinting. Uncontrolled pain also has deleterious effects on 
gastrointestinal and bladder functions due to release of catecholamines and stress hormones. 
Therefore a patient with poor pain control is at risk of respiratory dysfunction and surgical site 
infections, poor venous return and ileus among other complications[6-9]. 
POSTOPERATIVE PAIN IN INFANTS AND CHILDREN 
The impact of pain during and following surgical procedures in infants is now well recognised.This 
was not the case in the 19th and 20th centuries mainly due to the misconception that neonates did 
not experience pain due to what was thought to be underdeveloped nerual circuitry[lO] . The fact 
that the manifestation of pain in neonates, infants and children is different from adults contributed 
to this notion and lead to a practice where children, especially neonates and infants, underwent 
painful! procedures with minimal or no analgesia[ll]. 
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Neonates, infants and children may in fact suffer more adverse consequences of inadequate pain 
control when compared to adults due to a robust generalised inflamatory response and lack of 
central neural inhibition reflex[12, 13]. The longterm effects of a previous painful experience may be 
evident on followup and include a lowered threshold to noxious stimuli[14]. 
Although the pain control and monitoring for pain in children has improved from the 19th and 20th 
century, different surveys show that Infants and children are still at a higher risk of suffering from 
pain and its consequences[9, 15]. They are more likely to suffer pain more frequently and more likely 
to have suboptimal postoperative analgesia. Some of the contributing factors include the fear of side 
effects, especially from opiates, a misconception that pediatric pain control is complex and time 
consuming, non-application of pain assessment tools and lack of dedicated pediatric pain 
services[16, 17][16-20]. 
Pain management services are critical in the delivery of surgical care for children. Furthermore 
regular audits on pain management in every unit and research in post-operative analgesia in 
paediatrics are important for the development and adoption of more effective modalities[21]. 
Research on the efficacy and safety of new post-operative analgesia modalities in children has 
lagged behind when compared to the adult population. Studies in paediatric postoperative pain 
control have not shown a significant difference in hospital stay and return to function. Studies aimed 
at showing physiological gains (bowel and bladder function and physical activities) are also 
lacking[22]. 
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1.3 PAEDIATRIC POSTOPERATIVE ANALGESIA 
The mainstay of current post-operative analgesia regimens is multi-modal therapy. This includes pre-
emptive analgesia through local and regional nerve blockade peri-operatively and a combination of 
opioid and non-steroidal agents or paracetamol in the post-operative period [23]. The aim of multi-
modal pain therapy is to achieve near total pain control from the synergistic and additive effects of 
the drugs while reducing their individual side effects and potential complications[24, 25]. 
1.4 CONTINOUS LOCAL ANESTHETIC WOUND INFUSION (CLAWI) 
One of the modes of post-operative analgesia is the use of a multi-holed catheter placed in the 
wound to deliver a local anesthetic continuously. It allows continuous interruption of efferent 
nociception at the site of surgical trauma eliminating noxious stimulus sensation in the pain nerve 
circuitry[26] . 
The concept of local wound infusion is not new. Continuous local anesthetic wound infusion (CLAWI) 
has been used in obstetrics, gynecology, urology, thoracic surgery and colorectal surgery in adults 
with good efficacy and without increase in complications[27-29]. Although the safety and efficacy of 
CLAWI has been shown to a large extent, simple extrapolation of potential benefits of local wound 
infusion from the results involving adult populations cannot be made as the pharmacodynamics of 
the utilized agents is different in pediatrics[l3, 30]. 
The results of studies on the efficacy of continuous local anesthetic wound infusion in children have 
been published recently. They include patients undergoing urologic[31], thoracic[32] and abdominal 
procedures[33] and show a similar trend towards better or equivalent pain control with reduction in 
morphine requirements. The site of multi-holed wound catheter placement is dependent on the 
type of operation and preference. Placement of the catheter on the pre-peritoneal area or within 
the muscle fascia is associated with better pain control compared to the subcutaneous layer[22, 34]. 
At the time of this study CLAWI was not an option for post-operative analgesia at our center and 
within the African continent as a whole partly due to unavailability of multi-holed catheters , the 
relative lack of robust evidence for its use in children undergoing different abdominal operations 
and the fear of increased risk of infections. 
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1.5 PAIN ASSESSMENT IN POST-OPERATIVE PEDIATRIC PATIENTS 
There are several validated tools for pain assessment for non-verbal or neurologically impaired 
patients. There is a wide variety of pain assessment scales available to clinician . This allows one to 
choose the most appropriate means depending on the patient age, neurological status, and 
underlying disease. The ease of application and social/cultural factors that may influence the 
expression of pain are also important consideration in pain scale choice[35-37]. 
Pain assessment scales are useful in the monitoring and documenting pain scores in the 
postoperative period as well in research requiring pain measurement. Ideally all postoperative 
patients should have regular pain assessment as part of the vital sign measurements[38]. The best 
tool for assessment is the one that can be applied easily, has low inter-observer variability and is 
both sensitive and specific. In this study we used the Faces, Legs, Activity, Cry and Consolability 
(FLACC) scale[37], shown in 
Figure 1 & Appendix II. It is applicable in both the communicating and non-communicating pediatric 
patients, is already use in our center, easy to apply and requires a short duration of observation to 
make an assessment. To reduce the degree of inter-observer variability, this study had one pain 
specialist doing all the pain scores. 
- FLACC Behavioral Pain Assessment Scale - - - -
CAilGORIES SCORING 
0 1 2 
F~ e No particular expression or smile Occasional grimace or frown; Frequent to constant frown, clenched jaw, 
withdrawn, disinterested quivering chin 
Legs Normal position or relaxed Uneasy, restles5, tense Kicking or legs drawn up 
Adlvlty lying quietly, normal position, moves easily Squinning, shifting badt and forth, tense Arched, rigid, or jer1ting 
Cry No cry (awake or asleep) Moans or whimpers, occasional complaint Crying steadily, screams or sobs; frequent 
complaints 
Consolablllty Content, relaxed Reassured by occasional touching, hugging, Difficult to console or comfort 
or being talked to; distractable 
Figure 1: FLACC pain scale. 
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2.1 STUDY JUSTIFICATION 
HYPOTHESES 
CHAPTER 2: THE STUDY 
Given the results from the adult patient studies on continuous local anesthetic wound infusion, we 
inferred that there would be difference in post-operative pain control between pediatric patients 
undergoing subfascial wound bupivacaine infusion and those who receive continuous epidural 
bupivacaine infusion or continuous intravenous morphine infusion with or without adjunctive oral or 
rectal paracetamol. 
The use of an effective continuous local anesthetic wound infusion alone or in combination with 
other modalities is an attractive option for the following reasons: 
• It will obviate the need for the more invasive, technically demanding and time consuming 
epidural analgesia[39, 40]. 
o At our institution the placement of epidural catheters is done by an anesthesiologist who 
also follow-up its use and function. CLAW/ will reduce the workload on anesthesiologists. 
o Patients on epidural analgesia are nursed at least in a high care ward for continuous 
monitoring. This is because epidural catheters are prone to malfunction (leak, blockage 
or kink) or get dislodged besides other complications. CLAWI will reduce demand on high 
care beds 
o Some patients are unable to have an epidural catheter due to coagulopathy, associated 
spinal abnormality or other disease processes that increase the risk of epidural catheter 
placement[41]. CLAWI is applicable to a broader spectrum of patients 
• It will allow lower doses of opioid analgesia with a resultant decrease in the commonly 
associated side effects such as hypotension[36], nausea and vomiting, ileus, drowsiness and 
risk of apnea[42, 43]. 
• CLAWI requires less expertise for placement and does not require intensive post-operative 
monitoring[44]. 
• CLAWI is a more cost effective analgesia than epidural as the catheters are relatively 
cheaper 
• CLAWI is more suitable to the African continent as less skills in both anaesthetic and nursing 
field are required 
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2.2 OBJECTIVES OF THE STUDY 
PRIMARY OBJECTIVE: 
• To determine the efficacy of post -operative analgesia through local wound infusion compared 
to current standard of care among patients undergoing various abdominal operations: 
o As a surrogate marker for efficacy, the total morphine dose required as rescue analgesia 
was also recorded for each patient. 
SECONDARY OBJECTIVES: 
• Efficacy was also determined by pain scores measured by a single pain specialist who was 
blinded to the patient treatment arm. 
• To determine any associated complications with local wound infusion compared to standard 
post-operative pain management regimens. We recorded the following as complications: 
o Surgical site infections 
o Infusion catheter and epidural catheter blockage, leak, dislodgment 
o Bupivacaine adverse drug reactions 
o Morphine adverse drug reactions 
• To determine the postoperative course between groups in terms of physiologic parameters: 
o Time taken to tolerate feeds 
o Time to mobilization 
o The need for and duration of urethral catheterization 
o Length of hospital stay 
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2.3 MATERIALS AND METHODS 
SETIING 
The study was carried out in a tertiary level children's hospital with a wide referral basin. The care of 
post-operative patients initially takes place in a high-care section of the surgical ward or in the 
shared intensive care unit. A pain management service is available and comprises anesthesiologists, 
nurses trained in pain assessment as well as a specialist in pediatric pain assessment and 
management. The nursing staffs in these areas are also trained on the use of the Faces, Legs, 
Activity, Cry and Consolability (FLACC) scale. 
STUDY DESIGN 
A pilot study using the same inclusion and exclusion criteria to select sequential study participants to 
undergo continuous local wound infusion post operatively was conducted. This was to determine 
the feasibility and local acceptance of the study and included 15 patients (5 open appendectomy 
patients and 10 laparotomy patients) to undergo continuous local anesthetic wound infusion. In this 
series, all five appendectomy patients had complicated appendicitis, had average pain scores of 2.5, 
and no wound complications or bupivacaine related complications. The patients undergoing 
laparotomy for various conditions (liver biopsy-1, open pyelolithotomy-1, Wilm's tumor-2, 
diaphragmatic hernia-2, intestinal obstruction-1, hydatid cyst-1, Takayasu's disease-1, bladder 
reconstruction-1) had mean pain scores of 2.3, no bupivacaine related complications with 4 wound 
infusion catheter leaks particularly in the beginning. There were no wound infections in this cohort 
as well. 
Following the pilot study, a pain assessor-blinded randomized control trial was carried out in two 
parts running concurrently. The first part was to compare CLAWI to intravenous morphine and 
paracetamol in patients undergoing Lanz incision appendectomy. The second part was to compare 
continuous local anesthetic wound infusion to Epidural analgesia in patients undergoing laparotomy. 
Part I: 
This was a pain assessor-blinded randomized control trial involving pediatric patients undergoing 
open appendectomy via a Lanz incision for complicated appendicitis. Patients fitting the inclusion 
and exclusion criteria were randomly assigned to one of two arms once consent and assent was 
obtained. The intervention arm comprised those who would receive continuous local anesthetic 
wound infusion plus intravenous paracetamol with tapered intravenous morphine for rescue 
analgesia (CLAW!). The control arm comprised those who would receive tapered intravenous 
morphine plus intravenous paracetamol, that is, current standard post-operative analgesia (SAPA}. 
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Part I study population : 
Eligible patients comprised children between the age of 3 months and 12 years with a diagnosis of 
complicated appendicitis undergoing a Lanz incision open appendectomy. The diagnosis of 
appendicitis was based on clinical findings. Complicated appendicitis was determined by the 
attending clinician based on examination findings of a mass and/or peritonitis with a few patients 
requiring imaging for pre-operative confirmation. The decision for open appendectomy was made by 
the attending cl inician without prior knowledge on study group assignment. 
Part I patient selection : 
Inclusion criteria: 
o Age of 12 years and below 
o Surgical intervention via open appendectomy 
o Informed consent from legal guardian 
o Assent for patients 7 years old and above 
Exclusion criteria : 
o Laparoscopic appendectomy 
o Prolonged post-operative sedation and ventilation 
o Lack of assent for patients 7 years and older 
o Lack of informed consent from legal guardian 
Part II : 
This was a pain assessor-blinded randomized controlled trial involving pediatric patients undergoing 
various abdominal operations via laparotomy incisions for varied diagnoses. Eligible patients were 
assessed for inclusion and exclusion prior to random allocation to one of two groups once consent 
and assent was obtained. The intervention arm group comprised those who received continuous 
local wound infusion plus intravenous paracetamol and tapered intravenous morphine for rescue 
analgesia (CLAWI) . The control group comprised those who received continuous epidural analgesia 
plus intravenous paracetamol and tapered intravenous morphine for rescue analgesia (EPI). 
Part II study population: 
Eligible patients comprised children between the age of 3 months and 12 years undergoing planned 
open abdominal surgery for various conditions. The type and length of abdominal incision was 
determined by the surgeon. 
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Part II patient selection: 
Inclusion criteria: 
o Age of 12 years and below 
o Surgical intervention via laparotomy 
o Patients eligible for epidural analgesia 
o Informed consent from legal guardian 
o Assent for patients 7 years and older 
Exclusion criteria: 
o Laparoscopic abdominal surgery 
o Prolonged post-operative sedation and ventilation 
o Lack of informed consent from a legal guardian 
o Lack of assent for patients 7 years and older 
2.4 PROCEDURES 
SAMPLE SIZE CALCULATION 
We estimated a 25% to 50% difference in morphine requirements between the control (SAPA/EPI) 
and intervention(CLAWI) arms.[44]. Using the O'Brien-Fleming Continuity correction[45, 46] we 
required 45 participants in each group within the SAPA vs CLAWI arms and 25 participants in each 
group within the EPI vs CLAWI arm. This would be able to detect a difference of 20% in morphine 
requirement between the groups in each arm with 80% power and at a significance level (p-value) of 
0.05. 
Part of the protocol, an ethics board requirement, was to perform an interim analysis at 50% 
recruitment. This was powered to detect marked differences between the two arms and allow 
justification for conclusion or continuation of the study should either technique of analgesia prove 
significantly superior or inferior. 
RANDOMIZATION 
The patients were assessed for eligibility sequentially. This was done after clinical assessment and 
decision for surgery. Study participants fulfilling the inclusion criteria were subsequently randomly 
allocated to a study group. An online computer random number generator, 
(http://www.randomizer.org), was used to create the random number sequences for the two parts 
of the study. 
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BLINDING 
The pain assessor was blinded to the post-operative treatment allocation . Study participant group 
allocation was revealed only to the principal investigator, the operating surgeon, anesthesiologist 
and the data and safety management board. 
To ensure blinding during pain assessment, the patient wound dressings were identical in all groups 
and left in place for the duration of the study. Infusion pumps and the connections to the pumps 
regulating delivery of morphine, epidural and local anesthetics were identical as equipment is 
standardized in the hospital. 
2.5 POST-OPERATIVE ANALGESIA REGIMENS 
CONTINOUS LOCAL WOUND INFUSION 
Delivery of the local anesthetic to the wound was via a fenestrated (multi-holed) FG 2.5 inert tubing 
('lnfiltraLong', PANJUNK® catheter) (Figure 2). The fenestrations are designed to ensure equal 
outflow of fluid. The catheter was placed in the subfascial space at the time of wound closure. The 
subfascial layer is the potential space created at the time of wound closure between the sutured 
transversal is fascia and/or the posterior leaf of the rectus fascia as the floor with the overlying 
closed muscles and fasciae as the roof. 
Wound closure began with closure of the peritoneum and transversalis or rectus fascia to create the 
floor of the potential space. The tip of the catheter was positioned at the most lateral or cranial end 
of the wound. All the fenestrations lay along this floor. The non-fenestrated part of the catheter 
would then exit via a separate skin puncture site away from the wound, Figure 3. The catheter was 
then connected to a filter provided in the set. A Sml 0.9% saline bolus was then instilled through the 
filter to check for leaks and confirm appropriate placement of the fenestrated end of the catheter 
within the wound. The rest of the abdominal layers were then closed, the catheter exit site secured 
with adhesive dressing and the wound covered with opaque dressing. Before reversal from general 
anesthesia, a 0.1-0.2ml/kg bolus of 0.2% bupivacaine was administered through the filter connected 
to the wound infusion catheter and subsequently connected to a 50 ml syringe with 0.2% 
bupivacaine in 0.9% saline to run continuously using an electrical syringe driver set to run at 0.1-0.2 
mis/kg/hr. 
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Figure 2: Multi-hole wound infusion catheter 
Figure 3: Wound infusion catheter placed within the fascia 
EPIDURAL ANALGESIA 
Epidural catheter placement was performed by the anesthesiologist whilst the patient was under 
general anesthesia and before the surgical incision. Once the catheter position was confirmed, a 0.1-
0.2ml/kg bolus of 0.2% bupivacaine in 0.9% saline was administered. The catheter exit site was 
secured and trailed along the back of the patient with adhesive dressing. The epidural analgesia was 
run at 0.1-0.2ml/kg/hr during surgery. 
Surgery proceeded as planned and at conclusion and wound closure, an opaque dressing was 
applied to the wound. The epidural site was checked for leak or dislodgement after anaesthetic 
reversal and the infusion continued at recovery and in the ward. The epidural infusion was to run for 
up to a maximum of 72 hours as per protocol as longer infusions are associated with a rise in septic 
complications. 
2.6 POST-OPERATIVE ANALGESIA IN THE STUDY GROUPS 
PARTI 
Control group- Standard Post-operative analgesia (SAPA): 
The study participants received scaled intravenous morphine (0.5 mg per kilogram body weight 
mixed in 50 mis of 5% dextrose) at l-2ml per hour (i.e. 5-10 ug/kg/hr) and intravenous paracetamol 
(20mg/kg stat at reversal, then lSmg/kg every 4hrs ) then oral paracetamol at lSmg/kg every 4hours 
once oral intake was established. 
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Morphine infusion was started at 5ug/kg/hr. In case of pain as assessed by the attending staff, the 
rate was increased to lOug/kg/hr as per standard of care. Scaling down of morphine was by 
decrements of 2.5ug/kg/hr after every pain assessment once both the attending staff and pain 
assessor were satisfied that the study participant was not in pain 
Intervention group-Continuous local anesthetic wound infusion (CLAWI) : 
At wound closure the infusion catheter would be placed and managed as described above. 0.2% 
bupivacaine in 0.9% saline was infused continuously at a rate of O.l-0.2ml/kg/hr using an infusion 
pump. The local wound infusion was to run for up to a maximum of 72 hours. The study participants 
also received scaled intravenous morphine {0.5 mg per kilogram body weight mixed in 50 mis of 5% 
dextrose) at 1-2ml per hour (i.e. 5-10 ug/kg/hr) and intravenous paracetamol {20mg/kg stat at 
reversal, then lSmg/kg every 4hrs) then oral paracetamol at 15mg/kg every 4hours once oral intake 
was established. Morphine infusion was started at 5ug/kg/hr. In case of pain as assessed by the 
attending staff, the rate was increased to lOug/kg/hr as per standard of care. Scaling down of 
morphine was by decrements of 2.5ug/kg/hr after every pain assessment once both the attending 
staff and pain assessor were satisfied that the study participant was not in pain recurrence of pain. 
PARTII 
Control group- Epidural analgesia {EPI): 
The placement and peri-operative management of the epidural catheter has been described in the 
preceding paragraphs. 0.2% bupivacaine in 0.9% saline was infused at a rate of O.l-0.2mls/kg/hr 
using an infusion pump. Epidural infusion was for up to a maximum of 72 hours. 
The study participants assessed to be in pain at recovery also received scaled intravenous morphine 
{0.5 mg per kilogram body weight mixed in 50 mis of 5% dextrose) at 1-2ml per hour (i.e. 5-
lOug/kg/hr) and intravenous paracetamol (20mg/kg stat at reversal, then 15mg/kg every 4hrs) then 
oral paracetamol at 15mg/kg every 4hours once oral intake was established. 
Morphine infusion was started at 5ug/kg/hr. In case of pain as assessed by the attending staff, the 
rate was increased to lOug/kg/hr as per standard of care. 
Scaling down of morphine was by decrements of 2.Sug/kg/hr after every pain assessment once both 
the attending staff and pain assessor were satisfied that the study participant was not in pain 
recurrence of pain. 
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Intervention group- Continuous local anesthetic wound infusion (CLAWI): 
At wound closure the infusion catheter would be placed and managed as described above. 0.2% 
bupivacaine in 0.9% saline was infused continuously at a rate of 0.1-0.2ml/kg/hr using an infusion 
pump. The local wound infusion was to run for up to a maximum of 72 hours. 
The study participants assessed to be in pain at recovery also received scaled intravenous morphine 
{0.5 mg per kilogram body weight mixed in 50 mis of 5% dextrose) at 1-2ml per hour (i.e. 5-10 
ug/kg/hr) and intravenous paracetamol (20mg/kg stat at reversal, then 15mg/kg every 4hrs) then 
oral paracetamol at 15mg/kg every 4hours once oral intake was established. 
Morphine infusion was started at 5ug/kg/hr. In case of pain as assessed by the attending staff, the 
rate was increased to lOug/kg/hr as per standard of care. 
Scaling down of morphine was by decrements of 2.Sug/kg/hr after every pain assessment once both 
the attending staff and pain assessor were satisfied that the study participant was not in pain . 
2.7 RESCUE ANALGESIA 
For all study groups rescue analgesia was administered as intravenous morphine bolus at 
5micrograms per kilogram body weight over 10 minutes. This would be administered by the in-
house staff at any time as deemed necessary by the attending staff as per standard of care. The time 
and dose was recorded in the treatment chart. There was thus no analgesia restriction by study 
staff. All rescue analgesia was documented in the notes of the patient and transferred to the data 
sheet. 
2.8 PAIN ASSESSMENT PROTOCOL 
All patients in the study were assessed for pain by the same pediatric pain specialist, who was 
blinded to the treatment arms, using the same pain scale and at equal intervals of up to 6 hourly. 
The nursing staff are trained to do pain assessments using the FLACC scale, also assessed the 
patients for pain as per standard of care and the attending doctor was free to administer rescue 
morphine analgesia as required. 
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2.9 ASSESSMENT AND RECORDING OF OTHER OUTCOME MEASURES 
Assessment for passage of stool/flatus per rectum or stoma was by the attending clinician as per 
standard of care for all patients. 
Time to resumption of full feeds, episodes of vomiting, wound complications, sepsis, chest infection, 
time to mobilization out of bed, time to removal of urethral catheter, epidural catheter 
complications, peripheral line complications and time to discharge (duration of hospital stay) was 
recorded in the clinical notes by the attending surgeon. 
2.10 PATIENT MONITORING: 
All study participants were initially cared for in a high care setting with continuous pulse oximetery, 
regular blood pressure and temperature checks. The time spent in high care was determined by the 
attending clinician. The wound catheters and epidural catheters were checked daily for any signs of 
leak, kink, blockage or dislodgment by the anesthesia team and the investigator. Refilling of the 
bupivacaine syringe was by the investigator for wound infusion and by the anesthesia team for the 
epidural catheter as per the institutions epidural protocol. 
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CHAPTER 3: ETHICS OF THE STUDY: 
The study was assessed and approved both by the Red Cross War Memorial Children's Hospital 
research ethics committee and the University of Cape Town Human Research and Ethics Committee 
(Appendix Ill). 
All study participants were assessed for eligibility with strict inclusion and exclusion criteria. 
Informed consent was obtained for each participant. Assent was also obtained for participants older 
than 6 years. (Appendix IV) 
An initial pilot study was conducted to assess for safety, feasibility and local acceptance. 
Only the study number was used to identify each study participant on the database to avoid breach 
of confidentiality. Both the attending clinician and the study participant were free to withdraw 
consent for the study at any time during the study 
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CHAPTER 4: DATA MANAGEMENT 
4.1 OUTCOMES OF INTEREST 
• Primary outcome: 
o Total intravenous morphine dose in the control arms compared to the intervention arms. 
• Secondary outcomes: 
o Post-operative pain scores in the control arms compared to the intervention arms 
o Time to full mobilization in days 
o Time to resumption of full feeds in days 
o Wound complications: 
• Superficial surgical site infection 
• Deep surgical site infection 
• Organ space infection 
o Epidural and subfascial Catheter complications: 
• Blockage 
• Dislodgement or migration 
• Leakage 
• Infection 
o Other complications: 
• Morphine drug adverse drug reactions: 
Cardiovascular: hypotension, syncope, bradycardia, tachycardia 
Central nervous system: CNS depression, seizure 
Dermatologic: Pruritus 
Gastrointestinal: Nausea, vomiting, constipation, 
Genitourinary: Urinary retention requiring catheterization or re-
catheterization 
Respiratory: Respiratory depression 
Other: Anaphylaxis 
• Bupivacaine drug adverse drug reactions: 
Cardiovascular: Cardiac arrest, hypotension, bradycardia 
Central nervous system: Headache, restlessness, anxiety, seizures 
Dermatologic: Pruritus, angioneurotic edema 
Gastrointestinal: Nausea, vomiting 
Chest infections 
Hypotension 
Venous thrombosis or thromboembolism 
30 day mortality 
Time from skin incision to wound dressing 
Long term complications: 




4.2 DATA COLLECTION 
Data regarding all the outcomes of interest for all the study participants was collected through a 
data collection sheet using Microsoft, 2010 Excel® spread sheet which was predesigned for direct 
transfer onto a pre-coded database on Statistical Package for the Social Sciences (SPSS®) - IBM 2012, 
Version 21 for analysis. 
After recruitment each study participant was assigned a study number and allocated to a study arm 
as per the randomization procedure. The study number, group allocation, date of birth, date of 
surgery, date of discharge, gender, body weight and diagnosis was recorded. 
At the time of the surgery the data collection sheet was filled to indicate the type of incision, the 
length of incision (in centimeters) and wound class (O to 3). All the surgical incisions were 
categorized based on the wound classification system by the Centers for Disease Control and 
Prevention (CDC) for risk of surgical site infection. (See appendix I It classifies surgical wounds as 
clean, clean contaminated, contaminated or dirty. The risk of surgical site infection increases with 
the degree of contamination[45]. The time of incision and wound closure were also recorded. 
Pain assessment scores were charted by the pain specialist using the Faces, Legs, Activity, Cry and 
Consolability (FLACC) scale. The scale is from Oto 10, where O is no pain at all, 1-3 is mild discomfort, 
4-6 is moderate pain and 7-10 is severe pain ( 
Figure 1 & Appendix II). Each assessment session comprised two observations for 5 minutes each. 
The final score was then tabulated and the time recorded. The time of assessment and the pain 
score were then transferred onto the data collection sheet. 
The start and end date & time for morphine infusions were recorded on the treatment chart for 
each participant. This also included any morphine doses administered as rescue analgesia. The total 
dose of morphine, in micrograms per kilogram, required for each participant was then calculated by 
adding the total dose infused to the rescue morphine analgesia and entered onto the database. 
The date of surgery and dates when the participant tolerated enteral feeds, when the urine catheter 
was removed, when the participant was fully mobile and when the study participant was discharged 
from hospital were all entered onto separate columns on the data collection sheet. These dates 
were subsequently used to calculate the time intervals for the different secondary outcome 
measures. 
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Complications from epidural and wound catheters were assessed for daily by the anesthesia team 
and the investigator. These complications were coded for blockage, dislodgement or migration, 
leakage and infection and entered onto the data collection sheet. 
Wound infections were determined by the attending clinician. Wound infections were categorized 
according to Centers for Disease Control and Prevention (CDC} as superficial, deep or organ 
space[46]. Data on wound infections was coded for from O to 3 (O= no infection, !=superficial, 
2=deep and 3=organ space) and entered onto the data collection sheet for each study participant. 
Complications from morphine, paracetamol and bupivacaine were determined by the attending 
clinician and also looked for by the investigator in each study participant. This data was coded for 
and entered. 
Data collection was by. the principle investigator. All the data sheets were stored in a locked cabinet 
within the institution study center with access limited to the investigators. Transfer of data from the 
data collection sheet onto the computer Microsoft Excele 2010 was done by three trained research 
assistant volunteers. Double entry for each variable was performed. That is for each study 
participant data set two volunteers would enter the data separately and the data sets compared for 
consistency. Consistency checks were performed by one of the research assistants and checked a 
second time by the primary investigator. This computer database was stored in a single computer 
and the folder encrypted with a password. A password protected removable software memory stick 
was used as back-up. 
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CHAPTER 5: ANALYSIS 
Data was analyzed using IBM®SPSS® statistics Ver. 21 (2012). 
The two parts of the study (Appendectomy group and laparotomy group) were assessed separately. 
Within these two main study groups, the subgroup demographic, clinical variables and secondary 
outcome variables were analyzed for frequencies/percentage, means and standard deviation as 
appropriate. The Student's t-test was used for continuous variables and Chi-square for categorical 
variables to assess for differences between subgroups. Total morphine requirement as the primary 
outcome calculated for each patient and expressed as a mean and standard deviation for each 
subgroup. The Students t-test was used to compare morphine requirements between subgroups. 
Pain scores were recorded at multiple regular intervals for each study participant. A time series of 
pain scores for each subgroup was created and used to compare pain control trends between 
groups. A mean and standard deviation of the pain scores was also calculated and the means 
compared between subgroups using the t-test. 
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CHAPTER 6: RESULTS 
71 study participants were recruited in the study after initial assessment for eligibility out of 88 
potential study participants presenting for general surgery at Red Cross War Memorial Children's 
Hospital from January 2013 to January 2014. 34 potential study participants had a working diagnosis 
of complicated acute appendicitis and initially planned for open appendecectomy. Out of the 34, six 
were deemed not eligible (4 due to after-hours surgery and 2 due to change of diagnosis and 
management plan after further review and imaging. 54 potential study participants were planned for 
laparotomy for various diagnoses. Out of the 54, eleven were not eligible (6 due to after-hours 
surgery and 5 due to change of management plan with 3 having there elective surgery postponed 
after review of imaging post chemotherapy and 2 had planned post-operative ventilation). Out of 
the 71 study participants, 14 underwent open appendectomy and standard post-operative analgesia 
(APP-SAPA), 14 had open appendectomy and continuous local anesthetic wound infusion (APP-
CLAWI), 19 had laparotomy and epidural analgesia (LAP-EPI) and 24 had laparotomy and continuous 
local anesthetic wound infusion (LAP-CLAWI). llstudy participants were excluded from the final 
analysis; 1 in the APP-SAPA group, 2 in the APP-CLAW! group, 2 in the LAP-EPI group and 6 from the 
LAP-CLAW! group. The flow chart in figure 4 shows the recruitment process and reasons for 
exclusion in each subgroup. 
88 POTENTIAL STUDY PARTICPIANTS 
34 APPENDECECTOMY 
6 NOT ELLIGIBLE: 
After houn surgery - 4 
Olangc in management p~ 2 
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Figure 4: Flow chart of the study participant enrolment. 
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The APP-SAPA and APP-CLAWI subgroups (Table 1) were comparable in terms of age with a slightly 
higher female population in the control arm (62% vs 38%). All the study participants in the 
appendectomy group (APP-SAPA & APP-CLAWI) underwent a Lanz incision laparotomy. There was no 
difference in the length of incisions. All 12 participants in the APP-CLAWI subgroup had complicated 
appendicitis (perforated appendix, mass or collections) compared to 77% of the participants in the 
APP-SAPA subgroup. 




SURGERY PLANNIG URGENT 
EMERGENCY 
WOUND CLASS CLEAN 
CLEAN-CONT AM I NA TED 
CONTAMINATED/DIRTY 
COMPLICATED APPENDICITIS n(%) 
NON-COMPLICATED APPENDICITIS n(%} 
INCISION LEGHTH (CM) MEAN (STDEV) 
P-VALUE 
PAIN SCORE MEAN(STDEV) 
P-VALUE 
TOTAL MORPHINE REQUIREMENTS(Ug/Kg) MEAN(STDEV) 
P.VALUE 
SURGICAL SITE INFECTIONS INCISION SITE INFECTION 
DEEP 
DAYS TO FEED MEAN(STDEV) 
P-VALUE 
DAYS TO MOBILISE MEAN(STDEV) 
P-VALUE 
LENGTH OF HOSPITAL STAY MEAN(STDEV) 
P-VALUE 












































Table 1: Part 1 Study group Demographics, wound class, incisions length, pain score, morphine requirements, 
surgicaf site infection, days to feed & mobilize and length of hospital stay for the APP-SAPA vs APP-CLAW! 
subgroups. 
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In the laparotomy subgroups (Table 2 & 3), majority of the operations were elective in both groups. 
There were a higher percentage of males in the wound infusion arm. Most of the operations were 
classed as clean-contaminated and the length of incision was comparable. The number of study 
participants in the laparotomy group for specific surgical indications were few as shown in table 3. 
LAP·EPI (N=17) LAP·CLAWI (N=18) 
AGE (years) MEAN(STDEV) 4.4(4.1) 4.5(4) 
P-VALUE 0.398 
GENDER M 10(59%) 13(72%) 
F 7(41%) 5(28%) 
SURGERY PLANNIG ELECTIVE 11(65%) 11(61%) 
URGENT 69(35%) 7(39%) 
EMERGENCY 0 0 
WOUND CLASS CLEAN 2(11%) 3(16%) 
CLEAN-CONT AM I NA TED 15(89%) 11(61%) 
CONTAMINATED/DIRTY 0 4(23%) 
INCISIONS UPPER TRANSVERSE 12(70%) 10(56%) 
SUBCOSTAL 2(11%) 2(11%) 
MIDLINE 1(6%) 4(22%) 
PFANNESTEIL 2(11%) 1(6%) 
FLANK 0 1(6%) 
INCISION LENGTH (CM) MEAN (STDEV) 16.2 (5.2) 12.8 (5.4) 
P·VALUE 0.55 
PAIN SCORE MEAN(STDEV) 3.0(1.2) 2.4(1.2) 
P-VALUE 0.041 
TOTAL MORPHINE REQUIREMENTS(Ug/Kg) MEAN(STDEV) 406(200) 230(100) 
P.VALUE 0.052 
SURGICAL SITE INFECTIONS INCISION SITE INFECTION 0 0 
DEEP 0 0 
DAYS TO FEED MEAN(STDEV) 3.4(1.5) 2.2(1.8) 
P·VALUE 0.33 
DAYS TO MOBILISE MEAN(STDEV) 5.1(1.8) 4(1.9) 
P·VALUE 0.13 
LENGTH OF HOSPITAL STAY MEAN(STDEV) 7.2(3) 6(3) 
P·VALUE 0.6 
Table 2: Part 2 study group Demographics, wound class, incision types &length, pain score, morphine 
requ irements~ surgical site infection, days to feed & mobilize and length of hospital stay for the LAP-EPI vs LAP-
CLAWI subgroups. 
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1 1 




RENAL ATERY STENOSIS 
0 1 







Table 3: Indications for surgery in the laparotomy group. 
6.2 PAIN SCORES AND MORPHINE REQUIREMENTS 
Within the appendectomy groups (APP-SAPA & APP-CLAWI) there was a significantly lower average 
pain score of 2.5 in the CLAWI subgroups compared to 3.5 in the SAPA and 3.0 in the EPI subgroups. 
Morphine requirements were higher in the SAPA and EPI subgroups with the SAPA group requiring 
up to five fold the amount of morphine on average and EPI group requiring at least 50% higher the 
amount in the CALWI subgroup. 
The pain score trends were clustered at lower levels in the CLAWI subgroups in comparison to the 
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SUBGROUPS 
Figure 5: Pain score trends in the different study arms (APPSAP- appendectomy with standard analgesia, 
APPLAW-appendectomy with local anesthetic wound infusion, LAPEPl-laparotomy with epidural, LAPLAW-
laparotomy with local anesthetic wound infusion). 
6.3 DAYS TO MOBILISE 
The days to mobilization were shorter in the CLAWI group compared to the other groups with a 
significant difference between the APP-SAPA and APP-CLAWI subgroups of 2 days on average. On 
average the LAP-CLAWI subgroup was fully mobile one day earlier than the LAP-EPI subgroup. 
6.4 DAYS TO ENTERAL FEEDS AND DURATION OF HOSPITAL STAY 
There was no statistical difference in length of hospital stay and time to full enteral feeds between 
subgroups with a tendency to shorter stay and earlier enteral feed tolerance by one day for the 
CLAWI subgroups. 
6.5 URETHRAL CATHETERIZATION 
The requirement for urethral catheterization was higher in the EPI group. On average, among the 
CLAWI subgroup participants who had urine catheter inserted peri-operatively, the urine catheter 
was removed 2 days earlier compared to the SAPA and EPI subgroups. 
6.6 WOUND COMPLICATIONS 
There were no surgical site infections in the EPI and CLAWI groups. 3 Surgical site infections occurred 
in three participants in the APP-SAPA group (two deep incisional and one organ space). 
6.7 OTHER COMPLICATIONS 
There were no adverse drug reactions to morphine or bupivacaine. 
So far, none of the study participants has presented with incisional hernia or other delayed wound 
complications. 
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CHAPTER 7: DISCUSSION 
Post-operative analgesia is critical for optimal outcomes in surgery. Historically analgesia in 
pediatrics was seen as unnecessary or unimportant. This has changed with recognition that children 
suffer pain even in the neonatal period and their physiologic response to pain is actually markedly 
higher. Hence the current standard of care is to provide good analgesia postoperatively. 
However, there is a variation between centers on the modalities utilized for post-operative pain 
control. The extent of post-operative pain monitoring also varies and a dedicated pain service is not 
widely available especially in the resource constrained environments. Ideally, pain assessment 
should be one of the vital signs. The fear of adverse reactions to opiate analgesia and the lack of 
personnel trained in epidural analgesia for children are other important hurdles in the institution of 
multi-modal post-operative analgesia in pediatrics. 
Continuous local anesthetic wound infusion is an attractive option since it requires little expertise for 
infusion catheter placement. It also has the potential to reduce the need for opiate analgesia, 
urethral catheterization and intensive monitoring. The use of Continuous Local Anesthetic Wound 
Infusion {CLAWI) has been studied in adults undergoing different operations with promising results. 
CLAWI use in children is limited to a few centers. Studies on its efficacy in post-operative patients in 
pediatric surgery are few and vary in types operations, age groups and secondary outcome measures 
(time to enteral feeds, mobilization and other return of function surrogate markers). 
We conducted a pain assessor-blinded randomized control trial to compare continuous bupivacaine 
wound infusion to epidural bupivacaine analgesia and intravenous morphine in children undergoing 
different abdominal operations. The first part of the study included participants undergoing open 
appendectomy for complicated appendicitis. They were randomized to undergo either continuous 
local anesthetic wound infusion {APP-CLAWI) or standard post-operative analgesia (APP-SAPA). The 
second part of the study included participants undergoing open abdominal surgery for varied 
diagnoses. They were randomized to undergo either continuous local anesthetic wound infusion 
{LAP-CLAWI) or epidural analgesia (LAP-EPI). The two parts of the study ran concurrently between 
January 2013 and January 2014. 
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Out of 71 enrolled study participants we excluded 10. There was no significant overall variability 
within groups in age, gender, or type and length of incision. Pain scores were significantly in the 
lower trends and tended to remain low in the intervention arms (continuous local wound infusion -
CLAWI) compared to the control arms. Hidas and colleagues reported lower pain ratings with 
continuous incisional local infusion in pediatric patients undergoing major urological procedures[31]. 
The appendectomy (APP-SAPA) subgroup required up to five-fold more morphine compared to APP-
CLAWI subgroup. This was the total morphine requirements. Both groups received morphine 
infusion which was tapered off gradually. Due to ethical concerns we were not able to utilize a 
placebo nor could we start off without morphine infusion in both groups. This would have allowed 
the use of rescue morphine doses alone as an indicator of efficacy in this group. 
Within the laparotomy group, the epidural arm (LAP-EPI) required up to 50% more rescue morphine 
compared to the wound infusion arm (LAP-CLAWI). The morphine sparing effect of continuous local 
infusion in pediatrics has been shown by Hermansson [47] and Wang[33]. The marked difference in 
the need for opioid analgesia and pain score trends which was statistically significant albeit at a 
lower power (80%) in this study necessitated the conclusion of the study at this point 
Given the resulting smaller number of study participants in the subgroups, this study is not powered 
to detect a statistical difference in the other secondary outcomes. However there was a trend 
towards earlier resumption of full enteral feeds in the wound infusion subgroups by up to 2 days. 
Participants in the CLAWI subgroup also tended to mobilize earlier, few required urethral 
catheterization and in those whom a urine catheter was inserted, it was removed on average two 
days earlier. Wang et al reported earlier mobilization and reduced ileus in patients with continuous 
Ropivacaine wound infusion[33]. There was no difference in time to feeds and hospital stay in the 
study by Hermansson and colleagues[47]. It is possible that the trade-off for higher morphine doses 
to maintain acceptable pain control is the unwanted effect of prolonged ileus, urine retention and 
drowsiness. 
One of the concerns regarding wound infusion is the risk of surgical site infection particularly in the 
setting of a contaminated surgical field with a foreign body. Although the number of participants in 
the APP-CLAWI group with high risk CDC wound class was 3 compared to zero in the APP-SAPA 
group, no wound infections occurred in the former while three infections (2 superficial and 1 deep) 
occurred in participants in latter. It has been shown in vitro studies that different local anesthetic 
agents have a bacteriostatic effect on E.coli and other organisms that commonly result in surgical 
site infections[48]. However this has not been replicated in human and animal studies[49, SO]. 
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It is also possible that local anesthetic infusion alters the inflammatory response with improved 
tissue perfusion[Sl] . There are animal studies demonstrating reduced collagen production and 
wound strength by local anesthetics[S2]. This has raised concerns regarding the risk of poor healing 
and resultant incisional hernias in patients undergoing continuous local anesthetic wound infusion. 
The 3 month, short term, follow-up of participants in this study has so far not found a case of 
incisional hernia. Long term follow-up is necessary to detect any cases in the future. One significant 
complication of continuous local anesthetic is the risk of chondrolysis which has been reported in 
two adult patients with intra-articular local anesthetic infusion[S3]. 
Although CLAWI is not an indication for intensive monitoring on its own, it is crucial to ensure that 
the site of placement is correct, and hemostasis has been achieved. This is to avoid infusion into 
open vessels. Labeling of the syringes and the tubing should also be clear and all the staff taking care 
of the patient made aware as is the case for those on epidural analgesia. 
We did not do a cost-benefit analysis comparing CLAWI to the standard post-operative analgesia. 
The cost of the wound infusion catheter is most likely offset by the reduced need for urinary 
catheterization, ease of application and reduced need for other analgesics[S4] . The use of readily 
available and affordable material is going to reduce the cost while maintaining efficacy and safety of 
local anesthetic wound infusion[SS]. 
The weak points in this study are the low numbers particularly in the different indications for surgery 
in the laparotomy groups. The overall low numbers make it difficult to draw robust conclusions 
regarding the secondary outcomes as well. 
We also did not do a cost analysis for the wound infusion catheter. 
CONCLUSION: 
Continuous subfascial bupivacaine infusion is a reliable, safe and effective technique for post-
operative pain control in children undergoing open abdominal surgery. It is comparable to current 
standard of care and has reduced need for intravenous analgesia with a tendency to earlier 
resumption of enteral feeds and mobilization. 
RECOMMENDATIONS 
Continuous local anesthetic wound infusion should be one of the first line options for post-operative 
pain control in children undergoing open abdominal surgical procedures and future studies should 
look into the cost-benefits of the infusion catheter as well as the secondary endpoints. 
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APPENDICES 
APPENDIX - I: CDC wound infection risk 
Nontraumatic 
!Clean No inflammation encountered 
(class I) No break in technique 
Respiratory, alimentary, or genitourinary tract not entered 






Genitourinary tract entered in absence of infected urine 
Biliary tract entered in absence of infected bile 
Minor break in technique 
Major break in technique 
!Contaminated Gross spillage from gastrointestinal tract 
(class Ill) Traumatic wound, fresh 
Entrance of genitourinary or biliary tracts in presence of infected urine or bile 
Acute bacterial inflammation encountered, without pus 
Dirty and infected Transection of cleanrn tissue for the purpose of surgical access to a collection of pus 
(class IV) Traumatic wound with retained devitalized tissue, foreign bodies, fecal 
icontamination, delayed treatment, or all of these; or from dirty source 
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APPENDIX- II: FLACC scale 
- FLACC Behavioral Pain Assessment Scale --- _J - - - ·-- ·- - - --- --CAilGORIES SCORING 
0 1 2 
Face No particular expression or smile Occasional grimace or frown; Frequent to constant frown, clenched jaw, 
withdrawn, disinterested quivering chin 
l egs Normal position or relaxed Uneasy, restless, tense Kicking or legs drawn up 
Activity Lying quietly, normal position, moves easily Squinning, shifting back and forth, tense Arched, rigid, or jeri(ing 
Cry No cry (awake or asleep) Moans or whimpers, occasional complaint Crying steadily, screams or sobs; frequent 
complaints 
Consolablllty Content, relaxed Reassured by occasional touching, hugging, Difficult to console or comfort 
or being talked to; distractable 
How to Use the FLACC 
In patients who are awake: observe for 1 to 5 minutes or longer. Observe legs and body uncovered. Reposition patient or observe activity. Assess body for 
tenseness and tone. Initiate consoling interventions if needed. 
In patients who are asleep: observe for 5 minutes or longer. Observe body and legs uncovered. If possible, reposition the patient. Touch the body and assess 
for tenseness and tone. 
Face 
> Score O if the patient has a relaxed face, makes eye contact, shows interest in surroundings. 
> Score 1 if the patient has a worried facial expression, with eyebroM lowered, eyes partially closed, cheeks raised, mouth pursed. 
> Score 2 if the patient has deep furrows in the forehead, closed eyes, an open mouth, deep lines around nose and lips. 
legs 
> Score O if the muscle tone and motion in the limbs are normal. 
> Score 1 if patient has increased tone, rigidity, or tension; if there is intermittent flexion or extension of the limbs. 
> Score 2 if patient has hypertonicity, the legs are pulled tight, there is exaggerated flexion or extension of the limbs, tremors. 
Activity 
> Score O if the patient moves easily and freely, normal activity or restrictions. 
> Score 1 if the patient shifts positions, appeall hesitant to move, demonstrates guarding, a tense torso, pressure on a body part. 
> Score 2 if the patient is in a fixed position, rocking; demonstrates side-to-side head movement or rubbing of a body part. 
Cry 
> Score O if the patient has no cry or moan, awake or asleep. 
> Score 1 if the patient has occasional moans, cries, whimpers, sighs. 
> Score 2 if the patient has frequent or continuous moans, cries, grunts. 
Consolablllty 
> Score O if the patient is calm and does not require consoling. 
> Score 1 if the patient responds to comfort by touching or talking in 30 seconds to 1 minute. 
> Score 2 if the patient requires constant comforting or is inconsolable. 
Whenever feasible, behavioral measurement of pain should be used in conjunction with sef-report. When self-report is not possible, interpretation of pain behav-
iors and decisions regarding treatment of pain require careful consideration of the context in which the pain behaviors are observed. 
Interpreting the Behavioral Score 
Each category is scored on the ~2 scale, which results in a total score of ~10. 
0 = Relaxed and comfortable 4-6 = Moderate pain 
1-3 = Mild discomfort 7-10 = Severe discomfort or pain or both 
From Merkel, S. I., Voepel-lewts, T., Shayevltz, J. R., fr MaMyr,, S. (1997). The Fl.AC(: A beha-rloral scale for scoring postoperative pain In young children. Pediatric Nursing, 
23(3), 293-297. The Fl.ACC scale was developed by Sandra Merl<e/, MS, RN, Terri Voepel-Lewts, MS, RN, and Shobha MaMyr,, MD, at C. S. Mott Chlldren's Hospital, 
Unlvmity of Michigan Health Sysl<'m, Ann Arbor, Ml. Used with permission. 
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APPENDIX - Ill: Human Ethics and Research Committee study approval 
UNNERSITY OF CAPE TOWN 
" 
10 January 2013 
HREC REF: 135/2012 
Dr S Machoki 
Paediatric Surgery 
Red Cross War Memorial Children's Hospital 
Dear Dr Machoki 
Faculty of Health Sciences 
Human Research Ethics Committee 
Room E52-24 Groote Schuur Hospital Old Main Building 
Observatory 7925 
Telephone [021] 406 6338 • Facsimile [021] 406 6411 
e-mail: shuretta.thomas@uct.ac.za 
PROJECT TITLE: LOCAL ANAESTHETIC WOUND INFUSION VS STANDARDISED ANALGESIA 
IN PAEDIATRIC POST-OPERATIVE PAIN CONTROL: A DOUBLE BUND RANDOMISED 
CONTROL TRIAL 
Thank you for responding to the issues raised by the Faculty of Health Sciences Human Research 
Ethics Committee in your letter received on 8th January 2013. 
It is a pleasure to inform you that the HREC has formally approved the above-mentioned study. 
Approval is granted for one year till the 15tt, January 2014 
Please submit a progress form, using the standardised Annual Report Form if the study continues 
beyond the approval period. Please submit a Standard Closure form if the study is completed within 
the approval period. 
(Forms can be found on our website: www.health.uct.ac.za/research/humanethics/forms) 
Please note that the ongoing ethical conduct of the study remains the responsibility of the principal 
investigator. 
Please quote the HREC. REF in all your correspondence. 
Yours sincerely 
PROF OR M BL CKM N 
CHAIRPERSON, FHS HUMAN ETHICS 
Federal Wide Assurance Number: FWA00001637. 
Institutional Review Board (IRB) number: IRB00001938 
This serves to confirm that the University of cape Town Human Research Ethics Committee complies 
to the Ethics Standards for Clinical Research with a new drug in patients, based on the Medical 
Research Council (MRC-SA), Food and Drug Administration (FDA-USA), International Convention on 
Harmonisation Good Clinical Practice (ICH GCP) and Declaration of Helsinki guidelines. 
The Human Research Ethics Committee granting this approval is in compliance with the [CH 
Harmonised Tripartite Guidelines E6: Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) 




APPENDIX - IV: Consent & assent forms 
a) ENGLISH 
i) (STUDY PARTICIPANTS BELOW THE AGE OF 12 YEARS) 
Patient name: 
Date of birth 
File no. 
study no: ...... ...... .... .. .... ..... . . 
We (the RCWMCH local WOl.lld infusion investigators) are conduttino a study to establlsh the use of contiluous delivery of a 
local anesthetic ('pain reducer or pain medicine') to the WOlald by use of a sterle sm tubing placed in the WOtl1d dunng 
surgery. 
For study purposes, the study participant will either get the tubing plus pain medicine or not have the pain medicine delM!red 
althou!tl helshe wi haYe a tube. For those who will not be getting pain medicine ttwough the tubing, a tube wil be strapped on 
the study participant so that the one doing the study does not know who is getting extra pain medicine through the tube. The 
study parttj)ant and hisnler parent or guardian wil also not know if the pain med me is being delivered through the tube. This 
is to make the rest.Gs of the study more useful. 
The study wil not interfere in any way in the treatment d the ooderlying problem and the study participant · 1 be monitored 
regularly for adequate pain control and for any complications resulting from the sterie tubing or pain medicine. In case of pain 
the study participant wil have the usual pain control medicine (morphine, paracetamol, Valoron). If the study participant has 
any pain the doctors and runes wift !JM! hsnlher addiional mecftile to control it. In case of complications from the tubing or 
pain medicine, it wiD be stopped and the pain medicine delively tube removed by the doctor. 
This kind of treatment has been used safely in adults without increasin!l complications. 
The benefils of the study are to see if the medicine through the tube is better than the medicine through the veils and mouth or 
the back (spine). The risks of the medDle through the tube are infection, allergy or reaction to the medicine or the tube. The 
risks from the pain mecftile ttwough the veins and mouth include vomiting, drowsiness, allergy and olher reactions. The risks 
from the pain medicine through to the back include low blood pressure., difficufty passing I.Wine, allergy and other reactions. All 
this mediales have been used safely on the treatment of pain after surgery and )'OU wil be checked for any complications 
related to them. 
We need consent from the parents and/or guardians in order to place a catheter into the womd of the study p;irtq)anl cbing 
surgery and to administer the local anesthetic continuously through the catheter for up to n hoUJs after SL1gery. 
The study participant wil be monllored regularly while in the ward and will also be followed-up in the cine after discharge. 
lnllOIYernent in the study will not result in payment or promise of better care and non-ilYolvement wiR not result in any bias 
towards treatment of the t.lldedying condition. 
I (Name & Surname) .. ... .. .. ... ............. .. .......... .. . .. Sign.me ....... ........ ... ...... .... (Parent or legal guardian) 
Do give consent for the investigators lo place a WOlald infusioo tube into the wound of the above named study participant and 
to admnster a local anesthetic (pain mediate). 
Investigator (Name & SUmame): .... .. ... .. . ... .. ...... . ... .. .. ..... Signature .... .. . .. . ......... . . 
Witness (Name & Surname: ... .. . ... .... ... ...... . . ... . .. . .. . ..... . .. Signalllll .... ..... ... ... ... .. . 
Consent taken (Circle one): Per.;onaly Via Translator 
In case of any complaints or comments or questions regarding the study please contact: 
The Principal Investigator: 
And/Or 
Dr. stanJey M. Machoki 
Department of Pediatlic Surgery 
Redcross War Memolial Childrens Hospital 
P.O Box 7700 Rondebosch, Gape TO'Ml, RSA 
Tel: 0216585599 or 079591 1577 
Email: stanmugambi@Yahoo.co.ul 
The Groote Schuim- Human Research Ethics Committee: 
The Groote Schuur Human Research Ethics Committee 
Health Sciences Facutty 
E52, Rm 24, Old Main Build119 
Groote Schwr Hospital 
Tel: 021 406 6492 




ii) ENGLISH (STUDY PARTICIPANTS 7 TO 12 YEARS OF AGE) 
Patient name: 
Date of birth 
File no. . .. ......... ..... . ... .... ...... . 
Study no: ..... . ..... .......... .... .. ..... . 
We are conductilg a study to establish the use of continuous delivery of a local anesthetic {'pal reducef or pain med.cm') to 
the wound by use of a sterile small tubing placed in the WOllld during the operation. 
Should you choose to be included in the study, you wi either get pain medicine through the tubw1g pk.ls other pain medicine or 
not have the small tube in the wound but you will have pain mediale through the veins or into the back. In both cases we will 
watch you for any pain and increase the amount of pain medicine. The pain medicine is going to be reduced slowly as you 
recover and eventuaay changed to medic.ile that you can swallow orally near the time of <fischarge. 
Even if you do not get pain medicine through the tube in the 'MJUnd, you wil still have a covered tube attached to the side of the 
operation site so that we are able to do the study effectively since you and the person checking you for pain wil not know which 
kind of treatment you are getting. This will not mean that you wiD be without pain medicine. 
The study wiH not interfere in any way in the treatment of the problem that brought you to hosplal, you wil be checked regular1y 
by the doctor and the person ched(ing for pain. In case of pain the pain mediale be increased and we · be ched(ing for 
any problems caused by the pain me<fldne or the tube. 
This kind of treatment has been used safety in aduns without incll!asing complJcalions. 
The benefits of the study are to see if the medicine through the tube is better than the mediale through the veins or the back 
{spine). The risks of the medicine through the tube are infection, allergy or reaction to the medicine or the tube. The risks from 
the pain medicine through the vem include vomiting, drowsiness, allergy and other reactions. The risks from the pain medicine 
through to the back indude low blood pressure, difficulty passing urine, allergy and other reactions. All this medicines have 
been used safely on the treatment of pain after surgery and you wiU be ched(ed for any complic.iions related to them. 
We need yot.- permission to place the small tube into the wound during surgery and to give the local pain medicine 
continuously ttvough the catheter for up to 72 hours after ~ery. 
Your involvement in the study wiD not result in payment or promise of better care and non-involvement will not result in any 
penalty or poor treatment of the under1ying condition. 
I {Name & Surname) .... .. ... ...... .. ... ....... ... ... ......... Signature ... .......... .. .......... . . . 
Do give consent for the investigators to place a wound infusion tube into the WCU1d of the above named study participant and 
to actninister a local anesthetic {pain medicine). 
Investigator {Name & SUmame): .. . ... . .. .. . .... . .......... ... .... .. Signature .. ... .. . .... . ... .... . 
Witness {Name & Surname: .. ... . .. . .... .. ......... .. ........ .... . ... Signature ................. . .. . 
Consent taken (Circle one): Peisonally Via Translator 
In case of any complaints or comments or questions regarding the study please contact 
The Principal Investigator: 
And/Or 
Dr. stanley M. Machold 
Department of Pediatric Surgery 
Redcross War Memorial Childrens Hospital 
P .o Box noo Rondebosch, Cape Town. RSA 
Tel: 0216585599 or 07959115n 
Email: stanmugambi@Yahoo.co.ul 
The Groote Schuw Human Research Ethics Committee: 
The Groote Schuur Human Rese..-ch Ethics Committee 
Health Sciences Faculty 
E52, Rm 24, Old Main Building 
Groote Schuur Hospital 
Tel: 021 406 6492 
Fax: 021406 6411 
HREC/ REF: 13512012 
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ii) AFRIKAANS (STUDIEDEELNEMERS 7 TOT 12 JAAR OUD) 
Naam van pasient: 
Geboortedatum: 
Leemommer: ...... ....... ..... ......... .... . 
StudienorTmler: .. .......... ............. .... ... . 
Ons voer 'n studie uil om die gebruik van die volgehoue toediening van 'n plaaslike verdo ·ngsmiddel ("pynvertigter of 
pynmedisyne") aan die wond te vestig deur die gebruik van 'n steriele, klein buis wat gedurende die operasie in die wond 
geplaas word. 
lndien u Ides om aan die studie deel te neem, sal u of pynmedisyne deur <fie buis plus ander pynmedisyne kry of nie d"e kleWJ 
buis in die wond he nie, maar eerder pynmedisyne deur die are of in die rug kry. In albei gevalle sal ons u monitor vi" enige pyn 
en die hoeveelheid pynmedisyne vermeerder. Die pynmedisyne sal stadig verminder word soos u herstel, oo dit sal uiteindelik 
verander word na medisyne wat u kan mondeliks kan sit.* naby die tyd dat u ontslaan word. 
Selfs al ontvang u nie pynnedisyne deur die buis in die wond nie, sal u steeds 'n bedekte buis he wat aan die kant van die 
operasieplek geheg is soda! ons die studie doeltreffend kan litvoer aangesien u en die persoon wat u vi" pyn monitor nie sal 
weet watter tipe behandeling u ontvang nie. Oil beteken egter nie dat u sonder pynmedisyne sal wees nie. 
Hierdie studie sal geensins inmeng by die behandelslg van die probleem wat u na die hospitaal gebring het nie; u sal gereeld 
ondersoek word deur die dokter en die persoon wat u monior vir pyn. In die geval van pyn sal die pynmedisyne vermeerder 
word en ons sal ~ vir enige probleme wat deur die pynmedisyne of die buis veroorsaak word. 
Hierdie tipe behandeling is veiig gebruik in volwassenes sonder vermeerderde komplikasies. 
Die voordele van hierdie studie is om te bepaal of die medisyne deur die buis beter is as die medisyne deur die are of in die rug 
(ruggraat). Die risiko's van <fie medisyne deur <fie buis is infeksie, allergie of reaksie op die medisyne of die buis. Die risiko's 
van die pynmedisyne deur die ace sluit braking, lomerigheid, allefgie en ander reaksies in. Die risiko's van die pynmedisyne 
deur na die rug slUit lae bloeddruk, probleme om te urineer, alergie en ander reaksies in. Al hierdie medisyne is veilig gebruit 
om pyn na chirurgie te behandel, en u sal ondersoek 'M>fd vir enige komplikasies wat hiermee verband hou. 
Ons het u toestemming nodig om gedurende chirurgie die kleil buis in die VIIOOd te plaas, en om die plaaslike pynmedisyne 
voortdurend vir tot 72 uur na chirurgie deur die kateterte voer. 
U betrokkenheid by die studie sal nie lei tot betaling of die belofte van beter sorg en niedeelname sal nie in enige straf of swak 
behandelslg van die onderliggende toestand lei nie. 
Ek (Naam & Van) ... ... ......... ... . .. .... ... .... .. .. .. .. .. Handtekening ... ... . . .. .. . . . .. .. ..... ... . 
Gee toestemming vir die navorsers om 'n wondinfusiebuis in die wood van bogenoemde studiedeelnemers te plaas en om 'n 
plaaslite vefdowingsmiddel (pyrvnedisyne) toe te dien. 
Navor.;er (Naarn & Van): ...... ............. ............ .... . Handtettening .... ....... ... ... . .. . 
Getuie (Naam & Van: ... .. ........ ..... ........ .... ....... .. . . . Handtekening ..... . . .. .. .... ..... . 
Toestemming geneem (Omkmg een): Persoonlik Via Vertaler 
In die geval van enige klagtes, kommentaar of vrae rakende die studie kontak gerus: 
Die Hoofnavorser: 
En/Of 
Dr. Stanley M. Machold 
Departemoot van Pediatriese Chirurg·e 
Rooi Kruis-oortoggedenkhospitaal vir Kinders 
Posbus 7700, Rondebosch, Kaapstad, RSA 
Tel: 021 658 5599 of 079 591 1577 
E-pos: stanmuganbi@yahoo.co.ul 
Die Groote Schuur Menslike Navorsingsetiekkomitee: 
Die Groote Schuur Menslike Navorsingsetiekkomitee 
Fakulteit Gesondheidswetenskappe 
E52, Kamer 24, Ou Hoofgebou 
Groote Schuur-hospitaal 
Tel. : 021 406 6492 
Faks: 021 406 6411 
HREC/ REF:135/2012 
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c) lifomu zemvume 
i) ISINGESI (ABATHABATHI NKXAXHEBA KUPHANDO BAKWIMINYAKA 
ENGAPHANTSI KWESHUMI ELl-7) 
lgama lesigulane = I :ntua~ 
lnombolo yesifta,do sophando: . ..... ... ..... .. ..... '-- ------------------------' 
Tiwla(Baphandi beRCWMCH local "Mllnl infusion) senza izirundo zophando ngolrusetyenzisWa kwesilhomalalisi zinUoogu 
(ilocal aneslh£tic) kwisionda ngolwthi kuselyenziswe ilyhUbhu esuswe insholongwane ibeltwe esiondeni ngethuba lotyando. 
Ukuloogiselelwa uphando, 1.111thabathi nocaxheba uza kufumana ityhUbhu kunye nesi>ulala rtrtulgu okanye angafumani 
sb.tlali mtlungu lo~ efumene ityhubhu.Kwabo bangafumani zl>ulali zintulgu ngetylu>hu, ityhubhu iza kubotshelelwa 
klalthaba!hi nkxaxhel>a t.*wenzela uiuba owenza uphando angazi ukuba ngubani oza kutinlana isibulala zintrmgu 
esongezelelweyo kuselyenziswa ilyhubhu. Umthabathi nlocaxhel>a kmye nomzali okanye impelesi akazokuyazi U!Uba isibulali 
zintlungu zifakiwe kwityhubhu.Le nto iza kvienza ukuba iziphumo zophando zibe luncedo. 
Uphando alusayi kuphazamisana nonyango kwaye mithabathi nkxaxheba uza kusoloko ebekwe mso ukulawula iinfloogu 
ngendlela eyiyo nokubona naziphi na ingxaki ezmkubangelwa kuilt.lkwa kwetyhubhu okanye isi>ulali zi'ltkmgu.Kumba 
weentll.rlgu umthabalhi nkxaxheba uya kl.lll(wa isithomalalisi zintlmgu esiqhelekileyo fmorptme,~racetamol 
neValoron).Ukuba wnthabathi nkxaxheba uva iintlungu oogqirha nabongirazi bakwnongezelela isithomalalisi t*uziawula.xa 
kuthe kwakho ingXaki et>angelwa kukufakwa kwetyhubhu okanye isithanalalisi znlmgu, lwaku yekwa, sisuswe isilhomalaisi 
zintlungu esifakwa ngetyhubhu ngugqirha . 
Qiu hlobo lonyango selukhe lwasetyenziswa ngeml)tJmelelo kubantu abadala koogabangakho kU!hula kwazislgxaki .. 
linjongo zolu phando kukubona Ukuba iyeza xa lifakwe kwilyhubhu lingcono na kuneyeza elifakwe kwimilhambo, emlonyeni 
okanye kimnqonqo.lingxaki mioltubakho ngokufakwa kweyeza ngetyoobhu, zizifo, i-aleji, Ukungalmgelani neyeza okanye 
ttyrubhu.lingxaki ezi'lokubangelwa kUklt.lkWa kweyeza ngemilhambo okanye emlonyeni klJQU!a uiugabha, uiozela, i-aleji 
kwanezi'lye iimeko zokubt*ula iyeza.lingxaki ezibangelwa kuk\lakwa kwesibulafi ziintlmgu kumnqmqo yilowlJ pmsha(yilow 
blood pressure), ukudana nzima, i-aleji kunye nezilye ilmeko zokubUkula unyango.Onte anayeza asetyenziswa 
ngokukooselekileyo lrulhomalaliso lweentlllngu emva kotyando kwaye uza kujongwa nazi)hl na iingxaki ezinxulumene nazo. 
Sifuna imVl.llle yabazali okanye impetesi khon.ukuze sibe noluiaka ikhathetha kwisilonda somthabathi nlocaxheba ngethuba 
loqhaqho okanye ukufakwa kwesithomalalisi zintlmgu kwikhalhetha kangangeeyure emgama-n emva kotyando. 
Umthabathi nkxaxheba uya kubekwa aiso logana esewadini kwaye uyalumana ejongWa eklinikhi emva kokuba ekhululwe 
esibhedlele. 
Ukuthabatha ilkxaxheba kuphando akuzokuba nanzuzo yenllawulo okanye isithembiso sononophelo olungrono kwaye 
uklilQillhabathi nucaxheba akuzokubangela umkhelhe olhile . 
Mna(lgama neFani) .... .. .... .. ..... .... ... ... ... ... ... ... ... Umsayino .... .. ..... . . ... ... .. .... ... (Umzali okanye impelesi) 
Ndiyabanika invime abaphandi Uluba bafake ityhubhu kwisilonda somthabathi nkxaxheba okhankanywe ngezantsi 
kwanokuba anikwe izithomalalisi zi'ltlungu .. .. . .... . ... .... . 
Umphandi (lgama neFaru): ... ..... ... .... ......... ... ...... ... Umsayino ..... .. ... ........ . . . 
lngqina (lgama neFani) ... ..... .. .. ... .. .. .. ... .. .... ...... ... .. . Umsayw10 
lmV\ITie nciyinilezele (Yenza isangqa kwenye ): Ngokwam Ngetoiki 




UGqr stanley M. Machoki 
Department of Pediatric Surgery 
Redcross War Memorial Childrens Hospital 
P.O Box 7700 Rondebosch, Gape Town, RSA 
lnombolo yefowuni: 0216585599 or0795911577 
1-imeyile: starrnugambi@yahoo.co.ul 
IKomiti iGroote Schuur Human Research Ethics: 
The Groote Schuur Human Research Ethics Committee 
Health Sciences Faculty 
E52, Rm 24, Old Main Buildilg 
Groote Schuur Hospital 
lnombolo yefowuni: 021 406 6492 




ii) ISINGESI (ABATHABATHI NKXAXHEBA KUPHANDO BAPHAKATHI 
KWEMINY AKA ESl-7 neli-12) 
lgama lesigulana: 
Urnhla wolruz.alwa 
lnombolo yetayile. . . ......... . ...... ........ .. ... . 
lnombolo yesifi.lldo sophando: 
Senz.a izifundo zophando ngotusetyenziswa 
kwesithomalalisi m11mgu (ilocal anesthetic) kwisilonda ngolcuthi kusetyenziswe ityhubhu esuswe imsholongwane ibekwe 
esilondeni ngethuba lotyando. 
Ukuba ukhelhe ukuthabalha ilkxaxheba kuphando, uya kufumana isilhomalalisi zintuigu ngetyhubhu kooye nesihomalalisi 
ziltlungu ngomlomo okanye ungafakwa ityhubhu esiondeni kodWa uyaku fumana isithomalalisi zii~u siakwe emilhanjeni 
okanye kumnqonqo.Kwezi zehlo zozibini sakujonga ulruba akt*ho zilllungu zikhoyo songeze isithomalalisi 
:mtlungu.lsithomalalisi zintlunOu siza kuye siculhwa ekuye ineko ibuyela esiQhelweni elrugqjbeleni utshintshelwe kwiyeza oza 
k~ Ulisele xa kusondele ukukhulUIWa esibhedlele.Nokuba akutumani si!homalalsi zinth.11gu esifakwe kwitytn.Cll1u esilondeni, 
uya kunikwa ityhubhu ethiwe nca kweB cala lenziwe utyando khorfukuze senze uphando ngendlela eyiyo ngenxa yokuba wena 
nalo mntu uklljongayo ningazokuyazi ukuba loluphi Uhlobo lonyango olufumanayo.Le nto aylthelhi kuthi awuzokufumana 
izilhomalalisi ziOUl.llgU. 
Uphando oluzokuphazamisana nonyarigo lwesigulo sakho esikuzise esibhedlele, uza kujongwa rhoqo ngugqirha kwanomntu 
okujoriga ukuba alrukho ziltl\.ll!IWili naxa ki*ho iiOUungu isithomalalisi ziltlungu sakongezwakwaye kwakujongwa ~hi na 
iingxaki ezibangelwa sisithomalalisi zintlungu okanye iyhubhu. 
Olu hlobo lonyango selukhe lwasetyenziswa ngempumelelo kubantu abadala kll'lgabangakho kt.*hua kwazingxalci.. 
lnjoogo yolu phando kukubona ukuba xa iyeza lifakwa kwityhubhu kungcono na kunaxa Bfakwa ngemithambo okanye 
kumnqonqo .. lilgxaki zokufakwa kweyeza ngetyhubhu kukubakho kwezio, i-aleji okanye ukungall.llgetani neyeza okanye 
ityhubhu. lingxaki ezinokubangelwa kldrufakwa kweyeza ngemilhambo kUQtaa ukugabha. ukozela, i-alej kwanezinye iimek.o 
zokubukula iyeza.lingxaki ezibangelWa kukufakwa kwesibula ziltlungu kumnqonqo yilowu presha(yiloW blood pressure), 
ukuchama nzima, i-aleji k\.llye nezinye imeko zokubukula unyango. Onke amayeza asetyenziswa ngokukhuselekileyo 
ktahomalaliso lweentlungu emva kotyando kwaye uza kujongwa naziplj na i ngxaki ezilxulunlene nazo . 
Sifuna imvtme yabazafi okanye impelesi khon"ukuze sibe nokufalla idlalhelha kwisilonda somthabathi nlocaxheba ngethuba 
lotyando okanye uktr.*wa kwesithomalalisi ziltlungu kwikha!hetha kangangeeyure ezilgama-72 emva kotyando. 
Ukuthabatha kwakho inkxaXheba akuzokuba nanzuzo okanye isilhembiso SOl'lOOOl)helo okmgcono kwaye ukll'lgathabathi 
nkxaxheba akazokwenza kubekho isohlwayo okanye impatho mbi. 
Mna(lgama neFani) ... ... ...... .... . ... .... ......... ... . . .. . . Umsayi'lo ... . . . . .. . .. .. . ........ .... . 
Ndiyabanl!a imYlSTle abaphandi ukuba bafake ityhUbhu kwisilonda somthabalhi nkxaxheba okhankanywe ngezantsi 
kwanokuba banikwe iZilhomalalisi ziltlungu .... . .. ...... .. .. . 
Umphandi(lgama neFani): .. . .. . ..... . . . ... . ... ... .......... .. Umsayilo .... ...... ... .... .. . 
lngqila (lgama neFani: .. . ... ......... ...... .. . . ........ ..... . .. . Umsayn> .. .... ...... ........ . 
lmvume ndiyinikezele (Yenza isangQa kwenye): N!J()kwam Ngetolika 




UGqr stanley M. Machoki 
Department of Pediatric Surgery 
Redcross War Memorial Childrens Hospital 
P.O Box 7700 Rondebosch, cape Town, RSA 
lnombolo yefowuni: 0216585599 or0795911577 
lfeksi: stanmug.-nbi@yahoo.co.ut 
lkomiti iGroote Schuur Hwnan Research Ethics : 
The Groote Schuur Human Research Ethics Committee 
Health Sciences Faculty 
E52, Rm 24, Old Main Building 
Groote Schuur Hospital 
lnombolo yefowuni: 021 406 6492 
lfeksi: 021 406 6411 
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ASSEMENT FOR ELLIGIBILTY 






ATASHEET .4 • . ~ 
CONTROLGRO 
FILL PERI-OP D 
POST-OP RESC 
+PARACETAMO 







WOUND INFUSION CATHETER PLACEMENT 
FILL PERI-OP DATA SHEET 
POST-OP RESCUE MORPHINE+PARACETAMOL + WOUND 
INFUSION 
--.-.. 




FILL PERI-OP DATA SHEET 
j l POST-OP RESCUE ORPHINE 
, , +PARACETAMOL+ EPIDURAL 
-
WOUND INFUSION CATHETER REMOVAL AT 72 HOURS OR EARLIER IF COMPLICATION 
EPIDURAL CATHETER REMOVAL AT 72 HOURS OR EARLIER IF COMPLICATION 
DATA COLLECTION & ENTRY 
.. PROLONGED VENTILATION 
I' UNPLANNED MULTIPLE INCISION SITES ,, 
FOLLOW-UP 
PAIN AND WOUND ASSESSMENT 
DAT A COLLECTION & ENTRY 
~ • 
I DATA ANALYSIS: I 
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Appendix - VI: Data collection sheet 






Body Weight KG (XX.YY) 
Date of Birth DD-MM-YYYY 
Date of_surgery DD-MM-YYYY 
Date_of_Discharge DD-MM-YYYY 
Diagnosis 
Type of surgery ELECTIVE/EMERGENCY /URGENT 
Surgery PROCEDURE 
Antibioticl_at induction 
Antibiotic 2 at induction 
Antibiotic 3 at induction 
Other Antibiotics at induction 
lncision_TIME HH:MM 
Wound_closed TIME HH:MM 
Incision type 
Incision length CMs 
Wound infection risk CLEAN/CLEAN CONTAMINATED/CONTAMINATED 
Preincision_ analgesia 
Preincision_analgesia_type INTRAVENOUS/LOCAL/GAS 
Infusion catheter IN YES/NO 
Catheter IN date DD-MM-YYYY 
Catheter length CMs 
Catheter _infusion rate MLS/HOUR 
Catheter _infusion_boluses_ totalMLs MLS 
Catheter OUT_date DD-MM-YYYY 
Catheter infusionMLS total MLS 
Catheter_infusion BLOCKED YES/NO 
Catheter _infusion LEAK YES/NO 
Catheter infusion DISLODGED YES/NO 
Catheter infusion BLEEDING YES/NO 
Catheter_infusion INFECTION YES/NO 
Epidural INSERTED? YES/NO 
Epidural IN date DD-MM-YYYY 
Epidural_rate MLS/HOUR 
Epidural_boluses_total MLS 
Epidural OUT date DD-MM-YYYY 
Epidural_infusionMLs total MLS 
Epidural BLOCKED YES/NO 
Epidural LEAK YES/NO 
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Epidural DISLODGED YES/NO 
Epidural BLEEDING YES/NO 
Epidural INFECTION YES/NO 
Morphine_infusion_start_date DD-MM-YYYY 
Morphine boluses total MLS 
Morphine infusion stop date DD-MM-YYYY 
Morphine infusion total MLS 












Date STOOL DD-MM-YYYY 
Date SIPS DD-MM-YYYY 
Date ORALFLUIDS DD-MM-YYYY 
Date_FEEDS DD-MM-YYYY 
Number_VOMITS 
DATE_FULLY _MOBILE DD-MM-YYYY 
Date Urinecatheter IN DD-MM-YYYY 
Date_ Urinecatheter _ OUT DD-MM-YYYY 











ANY COMPLICATION AT 3MONTHS YES/NO IF YES WRITE COMPLICATION 
so 
